Last week, Israel’s IVC Research Center released the IVC-Meitar annual report, containing valuable insight regarding the Israeli tech industry’s corporate activities in 2020. The Report reviews the inbound venture investments, public capital market activities and M&A transactions involving Israeli companies.
The upshot of the report is that this challenging year did not stop the
Congratulations to our client Innoviz Technologies on going public. As recently reported by various media outlets, Innoviz Technologies, an Israeli technology and perception company, is going public through a $1.4 billion special purpose acquisition corporation (SPAC) deal with Collective Growth Corporation, and will be listed on NASDAQ under the ticker symbol INVZ.
Q. Assuming I properly received PPP funds, what can I spend it on?
A. The allowable uses of PPP loan funds are as follows:
Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life sciences industry.
The event will take place February 27th, 9:00 at Greenberg Traurig’s Tel Aviv office located in the Azrieli Round Tower (30th Floor).
Topics
Tel Aviv Managing Shareholder Joey Shabot and Of-Counsel Ephraim Schmeidler recently represented a US-based family office as part of its investment into Israeli company Sight Diagnostics Ltd (Sight). Sight develops a platform for diagnosing blood diseases using computer vision technology and is a portfolio company of Clal Biotechnology Industries Ltd., traded on the Tel Aviv
Last month, Mr. Boris Johnson, the Mayor of London was the guest of honor in the opening bell ceremony at the Tel Aviv Stock Exchange. This honorable visit comes in a time of growing and strengthening relations between the UK and Israeli business realms. In the words of Mr. Johnson, describing Israel – “